Levoreact Collirio Oftalmico 4 ml 0,5 mg per Occhi Allergici

Levoreact Ophthalmic Eye Drops 4 ml 0.5 mg for Allergic Eyes

it is used in the treatment of allergic conjunctivitis.

Dosage and method of use

Levoreact Oftalmico is used according to the following doses:

Adults and Children: the usual dose is 1 drop per eye, 2 times a day. The dose can be increased to 1 drop up to 3 or 4 times a day. Treatment should be continued for as long as it takes for symptoms to disappear.

Shake the bottle well before removing the cap. Each bottle contains approximately 120 drops. Patients should be informed of any precautions to be taken in order to avoid product contamination.

Contraindications Hypersensitivity 'to the active substance or to any of the excipients. Special warnings

Do not touch the eye with the bottle to avoid contaminating the rest of the product. As with all ophthalmic preparations containing benzalkonium chloride, propylene glycol and esters, patients should be advised not to use soft (hydrophilic) contact lenses during treatment as they can cause eye irritation. Remove contact lenses before applying the medicine and wait at least 15 minutes before putting them back on. The medicine discolours soft contact lenses.

Pregnancy and breastfeeding Pregnancy

Studies in animals have not shown embryotoxic or teratogenic effects. There are limited post-marketing data regarding the use of levocabastine eye drops suspension in pregnant women; the risk to humans is unknown, therefore Levoreact Ophthalmic should not be used during pregnancy unless the potential benefit to the woman justifies the potential fetal risk.

Feeding time

Based on levocabastine concentration determinations in the saliva and breast milk of a nursing woman given a single oral 0.5 mg dose of levocabastine, approximately 0.3% of the total levocabastine dose is expected administered ophthalmologically, can be transmitted to the infant. However, due to the limited availability of clinical and experimental data, caution is recommended when administering Levoreact Ophthalmic to breastfeeding women.

Expiry and retention

Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored.

Attention

do not use the medicine after the expiry date indicated on the package.

Composition

Levoreact Ophthalmic contains:
Active ingredient: propylene glycol, benzalkonium chloride
Excipients: Propylene glycol, sodium didrogen phosphate monohydrate, disodium hydrogen phosphate anhydrous, hydroxypropylmethylcellulose 2910, polysorbate 80, benzalkonium chloride, disodium edetate, water for injections.